Glycan-Targeted Virus-like Nanoparticles for Photodynamic Therapy
Biomacromolecules2012Vol. 13(8), pp. 2333–2338
Citations Over TimeTop 10% of 2012 papers
Abstract
Virus-like particles (VLPs) have proven to be versatile platforms for chemical and genetic functionalization for a variety of purposes in biomedicine, catalysis, and materials science. We describe here the simultaneous modification of the bacteriophage Qβ VLP with a metalloporphyrin derivative for photodynamic therapy and a glycan ligand for specific targeting of cells bearing the CD22 receptor. This application benefits from the presence of the targeting function and the delivery of a high local concentration of singlet oxygen-generating payload.
Related Papers
- → The good, the bad, and the ugly–controlling singlet oxygen through design of photosensitizers and delivery systems for photodynamic therapy(2018)154 cited
- → Explicit dosimetry for photodynamic therapy: macroscopic singlet oxygen modeling(2010)135 cited
- → In-vivo singlet oxygen dosimetry of clinical 5-aminolevulinic acid photodynamic therapy(2008)39 cited
- → Design of novel photosensitizers and controlled singlet oxygen generation for photodynamic therapy(2021)11 cited
- → Singlet oxygen dosimetry modeling for photodynamic therapy(2012)18 cited